TelyRx Holdings Inc. has seen a remarkable surge in its stock price, gaining over 13% in just one trading day.
In the latest trading session, TelyRx Holdings Inc. (TELY.TO) experienced a significant boost, closing at CA$2.50, marking a 13.64% increase. This surge is linked to the company's upcoming presentation at a key investor conference, which has sparked renewed interest among investors.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$73.09M
52W high
$4.25
52W low
$2.00
1W change
+10.20%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 122.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+122.2% Upside
Current Price
C$2.70
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
102.6%
Annualized
90-Day Vol
97.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.26
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.54 | C$1.79 โ C$3.62 |
| 60 trading days | C$2.40 | C$1.45 โ C$3.95 |
| 90 trading days | C$2.26 | C$1.22 โ C$4.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Keep an eye on TelyRx's upcoming conference presentation. It may provide valuable insights into the company's growth strategy and potential market opportunities.
TelyRx Holdings Inc. Gains 13.64% in One Day
The stock's market cap now stands at approximately CA$58.47 million, reflecting growing investor confidence.
Bull case
The upcoming Small Cap Growth Virtual Investor Conference is expected to draw significant investor attention. This could lead to more buying and further increases in the stock price.
Bear case
Despite the positive momentum, TelyRx's lack of profitability and high volatility could pose risks for investors, especially if the conference does not meet expectations.
Key Drivers of the Stock Surge
TelyRx's stock price increase is largely due to its participation in the Small Cap Growth Virtual Investor Conference. This event offers the company a chance to showcase its innovative digital pharmacy platform and engage directly with investors, which could lead to increased interest and investment in the company.
Market Reaction and Future Outlook
The market's positive response to TelyRx's news reflects a broader interest in healthcare technology stocks, particularly those that make accessing medications easier. However, investors should stay cautious, as the company's current financial metrics, including a negative profit margin, show that it is still in the early stages of its growth journey. Watching the outcomes of the conference will be crucial for assessing future performance.
Advertisement
